Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
about
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerNew Insights into the Crossroads between EMT and Stemness in the Context of CancerThe role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decisionA new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transitionPancreatic cancer stem cells: emerging target for designing novel therapyDuctal barriers in mammary epitheliumTwist: a molecular target in cancer therapeuticsDe-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signalingA critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistanceSecreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell propertiesRole of the Drug Transporter ABCC3 in Breast Cancer ChemoresistanceDownregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview.Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells.New insights into the role of EMT in tumor immune escape.Competing views on cancer.Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerBmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential.Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer.Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.ATP-binding cassette (ABC) transporter expression and localization in sea urchin development.Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysismiR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.Loss of Scribble Promotes Snail Translation through Translocation of HuR and Enhances Cancer Drug ResistanceExpression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.The "Sharp" blade against HIF-mediated metastasis.miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL23,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathwayThe tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasisHuman Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells.Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.Different Phases of Breast Cancer Cells: Raman Study of Immortalized, Transformed, and Invasive Cells.E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells
P2860
Q26741846-AF7E01B8-A380-48AD-9F73-BB93111C72D9Q26764831-88FA741E-7F22-4894-AC83-CBAEB42AF163Q26775618-B295CD54-2080-4C63-A994-8C4A3908EF8DQ26799171-2A4B7ED4-59EC-4D1D-966A-9D6DBA1C1505Q26863365-C374D755-678D-4440-8AA4-5DC5C9B100CCQ27023960-A2518D43-5EDA-45CA-B4C9-3B8D31D8518BQ28294941-77C5C2EA-FE6C-4B24-850E-0F6C0D223D93Q28542879-A7351520-4CD9-41FF-B34F-0B4BC803DCD6Q28543175-98E8159E-DD54-43D0-8BA3-5DE60BDB12E5Q28547688-5F6B3DCD-3A68-4D69-B015-9111113C917EQ28552011-F2F0C8EE-EBAC-4DD4-BC1E-88D5DF986A9FQ33654184-D8EC20B8-08B6-4969-AD1F-577CF20572B8Q33737290-4BB6D16F-F91C-49BB-8E39-BDF3F7660358Q33798970-821F5387-11D7-4E84-AD6B-C108C8458EC5Q33869781-57D01CF4-3161-489B-8534-46C116F8EAB0Q34060169-8162502D-63DA-4853-A9EB-3375019838CBQ34173709-CE3AC3A6-179F-4BF8-BDB2-5F1149C39398Q34202046-5FF968BD-55DF-424E-9129-137578B67656Q34469657-02135304-09D9-4C1C-BDDC-89F6FEDF982FQ34562135-DFF8CA7B-EC54-4C26-8565-3D4EDCC80942Q34786557-CCF59E8B-338C-4718-853E-533D2FE64009Q35051469-A92E95F4-600E-4D6A-9729-1476BD92C44EQ35535977-4A37EB2E-3E85-41D9-A557-9FD0E08B39EDQ35610049-467954D6-6811-4A42-BF6E-4BE4083AA2C0Q35687072-32D1BD6B-7149-4BAD-85E8-AB46684E9A3DQ35965806-C250A160-CA7F-48AC-9BE6-AC446ED362A0Q36095051-31F5F606-8C3F-48C3-B9B1-23E182BC47AAQ36135379-488D9301-3C7C-412A-B6D6-0ACD49DC9B67Q36259173-1922F0E1-A3F4-4D1C-807B-181B2577A350Q36394714-4AE5378C-8973-4E99-917C-D95944BD99D7Q36419257-17C9E2A4-BFF3-4190-AE71-A61056E81B3FQ36471883-08497507-6F01-48F6-872D-D0FA1348318CQ36581657-24197FA7-94DD-49B6-BF46-C5A00FF2231FQ36950630-C4F4A37B-7030-4B71-82A6-C26FAC5E6E9FQ37039887-74119929-5400-4A1C-88A6-F28FBB09C497Q37179521-48152D87-B76C-41EB-929A-372D7103C04CQ37368287-BAAE14B3-54D9-4410-BBA3-90ABBAEEC7D5Q37518671-DA2265F1-45C4-4360-B8FD-BF8C2B2AE8EFQ37539264-486954E0-C83F-4FFD-81A9-A119CD0394F6Q37716100-4E8A71D8-7FB1-45A2-B531-AB8B818A0555
P2860
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transcription factors that med ...... upregulating ABC transporters.
@ast
Transcription factors that med ...... upregulating ABC transporters.
@en
type
label
Transcription factors that med ...... upregulating ABC transporters.
@ast
Transcription factors that med ...... upregulating ABC transporters.
@en
prefLabel
Transcription factors that med ...... upregulating ABC transporters.
@ast
Transcription factors that med ...... upregulating ABC transporters.
@en
P2093
P2860
P356
P1476
Transcription factors that med ...... upregulating ABC transporters
@en
P2093
A Rangarajan
M A Stephens
P2860
P356
10.1038/CDDIS.2011.61
P50
P577
2011-07-07T00:00:00Z